Review
Published on 16 Sep 2022
Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.946030
- 6,037 views
- 10 citations
Type at least 3 characters
1,645 articles
Articles
Original Research
Published on 16 Sep 2022
Emergence of high colistin resistance in carbapenem resistant Acinetobacter baumannii in Pakistan and its potential management through immunomodulatory effect of an extract from Saussurea lappa
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.986802
- 4,209 views
- 5 citations
Brief Research Report
Published on 14 Sep 2022
Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.991448
- 2,145 views
- 9 citations
Original Research
Published on 14 Sep 2022
Peripheral and intestinal mucosal-associated invariant T cells in premature infants with necrotizing enterocolitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1008080
- 1,998 views
- 3 citations
Original Research
Published on 13 Sep 2022
Icariin protects vertebral endplate chondrocytes against apoptosis and degeneration via activating Nrf-2/HO-1 pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.937502
- 6,237 views
- 32 citations
Review
Published on 13 Sep 2022
How sphingolipids affect T cells in the resolution of inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1002915
- 4,789 views
- 14 citations
Review
Published on 13 Sep 2022
The regulatory mechanism and potential application of IL-23 in autoimmune diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.982238
- 6,056 views
- 11 citations
Original Research
Published on 13 Sep 2022
Central administration of human opiorphin alleviates dextran sodium sulfate-induced colitis in mice through activation of the endogenous opioid system
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.904926
- 5,884 views
- 6 citations
Review
Published on 13 Sep 2022
Interleukin 22 and its association with neurodegenerative disease activity
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.958022
- 3,252 views
- 13 citations
Review
Published on 12 Sep 2022
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1002871
- 7,306 views
- 10 citations
Original Research
Published on 12 Sep 2022
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.958687
- 2,340 views
- 5 citations
Original Research
Published on 09 Sep 2022
The interaction of MD-2 with small molecules in huanglian jiedu decoction play a critical role in the treatment of sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.947095
- 3,045 views
- 5 citations
Correction
Published on 09 Sep 2022
Corrigendum: TAZ induces migration of microglia and promotes neurological recovery after spinal cord injury
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.995767
- 1,036 views
- 1 citation
Review
Published on 09 Sep 2022
Compounds purified from edible fungi fight against chronic inflammation through oxidative stress regulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.974794
- 4,070 views
- 5 citations
Correction
Published on 08 Sep 2022
Corrigendum: Circadian rhythm protein Bmal1 modulates cartilage gene expression in temporomandibular joint osteoarthritis via the MAPK/ERK pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.971840
- 1,648 views
Review
Published on 08 Sep 2022
The critical role of ferritinophagy in human disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.933732
- 8,989 views
- 28 citations